Jakob Theorell
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jakob Theorell, MD, PhD, researches at the Yenan Bryceson Group, based at the Center for Infectious Medicine, in Karolinska Institutet in Stockholm, Sweden with his work focusing on understanding the mechanisms of disease in patients suffering from chronic immunodeficiency syndromes.[1]
Doctorate thesis[edit | edit source]
- 2017 - Understanding Chronic Immunodeficiency Disorders Through Assessment of Cytotoxic Lymphocyte Function - (Full text)
Notable studies[edit | edit source]
- 2017 - Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients[2] - (Full text)
Talks and interviews[edit | edit source]
- 2017, Speaker at the 12th Invest in ME International ME Conference; Speech title: "Studies of NK cells and cytotoxic T-cells in ME-patients from one Swedish and one Norwegian cohort"[3] - (Video)
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ "Yenan Bryceson group | Karolinska Institutet". ki.se. Retrieved February 25, 2020.
- ↑ Theorell, Jakob; Bileviciute-Ljungar, Indre; Tesi, Bianca; Schlums, Heinrich; Johnsgaard, Mette Sophie; Asadi-Azarbaijani, Babak; Strand, Elin Boole; Bryceson, Yenan T. (2017), "Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients", Frontiers in Immunology, doi:10.3389/fimmu.2017.00723
- ↑ http://www.investinme.org/iimec12.shtml
